abstract |
The invention relates to peptides as well as pharmaceutical compositions comprising immunogenic peptides of a T cell receptor (RCT) marking characteristic of an immune disease, capable of preventing, suppressing or treating the disease. According to a preferred embodiment, the amino acid sequence of the peptide corresponds to at least part of a complementary determining region (RDC) of a hypervariable region of the RCT. The invention also relates to antibodies and / or T cells reacting immunologically with the RCT peptide, capable of preventing, suppressing or treating an immune disease by passive transfer. |